Drug
BMS-247550
BMS-247550 is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
20%(1 trials)
Phase Distribution
Ph phase_2
2
40%
Ph phase_1
3
60%
Phase Distribution
3
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
3(60.0%)
Phase 2Efficacy & side effects
2(40.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 13 (60.0%)
Phase 22 (40.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_1
BMS-247550 in Treating Patients With Cancers That Have Not Responded to Previous Therapy
NCT00020371
completedphase_1
Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer
NCT00005807
completedphase_1
S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction
NCT00049400
completedphase_2
BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer
NCT00022477
completedphase_2
BMS 247550 to Treat Kidney Cancer
NCT00030992
Clinical Trials (5)
Showing 5 of 5 trials
NCT00020371Phase 1
BMS-247550 in Treating Patients With Cancers That Have Not Responded to Previous Therapy
NCT00005807Phase 1
Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer
NCT00049400Phase 1
S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction
NCT00022477Phase 2
BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer
NCT00030992Phase 2
BMS 247550 to Treat Kidney Cancer
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5